CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
30 juil. 2024 02h00 HE
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
29 juil. 2024 08h00 HE
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
Continuous Renal Replacement Therapy Market is Expected to Reach $2.1 Billion | MarketsandMarkets.
19 déc. 2023 18h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Continuous Renal Replacement Therapy market in terms of revenue was estimated to be worth $1.4 Billion in 2023 and is poised to reach $2.1 billion by 2028,...
Continuous Renal Replacement Therapy (CRRT) Market Size to Surpass USD 1.76 Billion by 2030, exhibiting a CAGR of 7.8%
26 oct. 2023 06h07 HE
|
Fortune Business Insights
Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Global Continuous Renal Replacement Therapy (CRRT) market size was valued at USD 1.01 billion in 2022 The market is anticipated to expand from USD 1.76...
Continuous Renal Replacement Therapy (CRRT) Market to Cross $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
02 févr. 2023 20h45 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the new market research report Published by MarketsandMarkets, "Continuous Renal Replacement Therapy Market by Product (Disposables...
SeaStar Medical’s Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting
07 nov. 2022 12h30 HE
|
SeaStar Medical Holding Corporation
– The SCD is currently being evaluated by the FDA for a Humanitarian Device Exemption (HDE) marketing approval for use in children (> 20 kgs) with AKI – The Company expects the FDA to complete...
Nuwellis to Advance Treatment of Critically-Ill Children and Babies Under $1.7 Million NIH Grant
05 août 2021 08h00 HE
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Critically-ill children and babies with kidney failure or who are dependent on artificial kidney support currently do not have enough...
Jafron Biomedical Announces Global Advisory Board
21 juin 2021 07h00 HE
|
Jafron Biomedical Co.,Ltd.
ZHUHAI, China, June 21, 2021 (GLOBE NEWSWIRE) -- Jafron Biomedical, a pioneer in the blood purification industry, announced it's founding the Global Advisory Board, which includes the world’s top...